Advertisement
Screener

CME GROUP INC. (CME) Spending and interest coverage

CME GROUP INC. (CME) Spending and interest coverage

  • R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
  • Stock-based compensation / revenue · 12 months: Value 1.47%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
  • Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..

Spending and interest coverage

Overview →

Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.

MetricValueFormula and calculation
R&D / revenue · 12 months(m)Research and development expense / revenue. Period ending 2026-06-30.

Calculation unavailable: missing inputs remain (m).

Stock-based compensation / revenue · 12 months1.47%Share-based compensation / revenue. Period ending 2026-06-30.

$99.50M ÷ $6.77B × 100 ≈ 1.47%

Interest coverage · 12 months(m)Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified.

Calculation unavailable: missing inputs remain (m).

Calculation inputs

InputAmount with unitRaw financial data
Research and development spending(m)
Revenue6.77B USD
Stock-based compensation99.50M USDShare-based Payment Arrangement, Noncash Expense
Operating income4.41B USDOperating Income (Loss)
Interest expense · reported / estimated(m) · Estimated expense assumptions

Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.

Calculated history

Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.

Period endingResearch and development spending (USD)Revenue (USD)Stock-based compensation (USD)Operating income (USD)Interest expense · reported / estimated (USD)R&D / revenueSBC / revenueInterest coverageInterest expense basis
2026-06-30(m)$6.77B$99.50M$4.41B(m)(m)1.47%(m)(m)
2026-03-31(m)$6.76B$95.40M$4.43B(m)(m)1.41%(m)(m)
2025-12-31(m)$6.52B$94.80M$4.23B(m)(m)1.45%(m)(m)
2025-09-30(m)$6.40B$93.00M$4.16B(m)(m)1.45%(m)(m)
2025-06-30(m)$6.44B$89.30M$4.21B(m)(m)1.39%(m)(m)
2025-03-31(m)$6.28B$87.40M$4.08B(m)(m)1.39%(m)(m)
2024-12-31(m)$6.13B$89.50M$3.93B(m)(m)1.46%(m)(m)
2024-09-30(m)$6.04B$86.70M$3.85B(m)(m)1.43%(m)(m)
2024-06-30(m)$5.80B$85.30M$3.64B(m)(m)1.47%(m)(m)
2024-03-31(m)$5.63B$86.00M$3.48B(m)(m)1.53%(m)(m)
2023-12-31(m)$5.58B$82.90M$3.44B(m)(m)1.49%(m)(m)
2023-09-30(m)$5.35B$84.10M$3.24B(m)(m)1.57%(m)(m)
2023-06-30(m)$5.24B$84.60M$3.16B(m)(m)1.62%(m)(m)
2023-03-31(m)$5.11B$84.50M$3.07B(m)(m)1.65%(m)(m)
2022-12-31(m)$5.02B$84.30M$3.02B(m)(m)1.68%(m)(m)
2022-09-30(m)$4.96B$77.40M$2.98B(m)(m)1.56%(m)(m)
2022-06-30(m)$4.84B$73.60M$2.85B(m)(m)1.52%(m)(m)
2022-03-31(m)$4.78B$73.60M$2.78B(m)(m)1.54%(m)(m)
2021-12-31(m)$4.69B$75.20M$2.65B(m)(m)1.60%(m)(m)
2021-09-30(m)$4.64B$83.30M$2.53B(m)(m)1.79%(m)(m)
2021-06-30(m)$4.61B$91.50M$2.44B(m)(m)1.98%(m)(m)
2021-03-31(m)$4.61B$94.50M$2.40B(m)(m)2.05%(m)(m)
2020-12-31(m)$4.88B$96.00M$2.64B(m)(m)1.97%(m)(m)
2020-09-30(m)$4.92B$71.60M$2.70B(m)(m)1.45%(m)(m)
2020-06-30(m)$5.12B$62.20M$2.86B(m)(m)1.21%(m)(m)
2020-03-31(m)$5.21B$77.90M$2.92B(m)(m)1.50%(m)(m)
2019-12-31(m)$4.87B$73.10M$2.59B(m)(m)1.50%(m)(m)
2019-09-30(m)$4.97B$116.80M$2.66B(m)(m)2.35%(m)(m)
2019-06-30(m)$4.59B$119.00M$2.53B(m)(m)2.59%(m)(m)
2019-03-31(m)$4.38B$97.10M$2.50B(m)(m)2.22%(m)(m)
2018-12-31(m)$4.31B$96.50M$2.61B(m)(m)2.24%(m)(m)
2018-09-30(m)$3.97B$65.70M$2.50B(m)(m)1.65%(m)(m)
2018-06-30(m)$3.96B$64.20M$2.51B(m)(m)1.62%(m)(m)
2018-03-31(m)$3.82B$60.80M$2.45B(m)(m)1.59%(m)(m)
2017-12-31(m)$3.64B$58.00M$2.31B(m)(m)1.59%(m)(m)
2017-09-30(m)$3.66B$66.70M$2.31B(m)(m)1.82%(m)(m)
2017-06-30(m)$3.61B$63.90M$2.27B(m)(m)1.77%(m)(m)
2017-03-31(m)$3.59B$65.10M$2.23B(m)(m)1.81%(m)(m)
2016-12-31(m)$3.60B$66.20M$2.20B(m)(m)1.84%(m)(m)
2016-09-30(m)$3.50B$57.90M$2.13B(m)(m)1.66%(m)(m)
2016-06-30(m)$3.50B$57.10M$2.12B(m)(m)1.63%(m)(m)
2016-03-31(m)$3.42B$62.10M$2.06B(m)(m)1.82%(m)(m)
2015-12-31(m)$3.33B$60.80M$1.99B(m)(m)1.83%(m)(m)
2015-09-30(m)$3.35B$59.10M$1.99B(m)(m)1.76%(m)(m)
2015-06-30(m)$3.27B$62.10M$1.90B(m)(m)1.90%(m)(m)
2015-03-31(m)$3.18B$56.30M$1.82B(m)(m)1.77%(m)(m)
2014-12-31(m)$3.11B$54.80M$1.77B(m)(m)1.76%(m)(m)
2014-09-30(m)$2.96B$54.90M$1.62B(m)(m)1.86%(m)(m)
2014-06-30(m)$2.91B$54.80M$1.59B(m)(m)1.88%(m)(m)
2014-03-31(m)$3.00B$55.20M$1.69B(m)(m)1.84%(m)(m)
2013-12-31(m)$2.94B$54.40M$1.64B(m)(m)1.85%(m)(m)
2013-09-30(m)$2.91B$53.00M$1.69B(m)(m)1.82%(m)(m)
2013-06-30(m)$2.88B$52.40M$1.68B(m)(m)1.82%(m)(m)
2013-03-31(m)$2.86B$59.50M$1.65B(m)(m)2.08%(m)(m)
2012-12-31(m)$2.91B$61.40M$1.69B(m)(m)2.11%(m)(m)
2012-09-30(m)$2.99B$62.60M$1.71B(m)(m)2.09%(m)(m)
2012-06-30(m)$3.18B$61.60M$1.88B(m)(m)1.94%(m)(m)
2012-03-31(m)$3.22B$53.60M$1.95B(m)(m)1.66%(m)(m)
2011-12-31(m)$3.28B$51.30M$2.02B(m)(m)1.56%(m)(m)
2011-09-30(m)$3.31B$50.50M$2.09B(m)(m)1.53%(m)(m)
2011-06-30(m)$3.17B$46.70M$1.96B(m)(m)1.47%(m)(m)
2011-03-31(m)$3.14B$43.60M$1.94B(m)(m)1.39%(m)(m)
2010-12-31(m)$3.00B$40.90M$1.83B(m)(m)1.36%(m)(m)
2010-09-30(m)$2.91B$37.70M$1.78B(m)(m)1.30%(m)(m)
2010-06-30(m)$2.83B$35.40M$1.73B(m)(m)1.25%(m)(m)
2010-03-31(m)$2.66B$34.10M$1.62B(m)(m)1.28%(m)(m)
2009-12-31(m)$2.61B$33.40M$1.59B(m)(m)1.28%(m)(m)
2009-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2009-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2009-03-31(m)(m)(m)(m)(m)(m)(m)(m)(m)
2008-12-31(m)$2.56B$37.60M$1.58B(m)(m)1.47%(m)(m)
2008-09-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2008-06-30(m)(m)(m)(m)(m)(m)(m)(m)(m)
2007-12-31(m)$1.76B$22.90M$1.05B(m)(m)1.30%(m)(m)

(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.

Similar stocks

Stock NameCountryMarket CapPE Ratio
LPL Financial Holdings Inc. (LPLA)United States$23.839B22.38
StoneX Group Inc. (SNEX)United States$8.386B26.96
Cboe Global Markets, Inc. (CBOE)United States$27.926B18.70
NASDAQ, INC. (NDAQ)United States$52.840B22.52
Intercontinental Exchange, Inc. (ICE)United States$88.072B17.10